Skip to content

salamander U: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

salamander U

BE 0640.885.928
NACE 21.209, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€377,660
2024 · -€369,958-€7,702
Equity
€1.0m
2024 · €1.4m-€377,660
Cash
€377,014
2024 · €1.3m-€882,001
Balance sheet total
€3.4m
2024 · €3.1m+€366,491

Largest movements

2024 to 2025
Assets
  • Cash -€882,001

    down €882,001 (-70.1%), from €1.3m to €377,014

    mainly Receivables within one year (-€572,038) and Deferred charges and accrued income (-€426,925)

  • Receivables within one year +€572,038

    up €572,038 (+223.6%), from €255,863 to €827,901

    of which Trade receivables: +€529,465

  • Deferred charges and accrued income +€426,925

    up €426,925 (+35.6%), from €1.2m to €1.6m

  • Intangible fixed assets +€189,217

    up €189,217 (+223.5%), from €84,645 to €273,863

  • Stocks and contracts +€57,233

    up €57,233 (+153.7%), from €37,226 to €94,459

Equity and liabilities
  • Accrued charges and deferred income +€842,311

    up €842,311 (+110.8%), from €760,530 to €1.6m

  • Profit (loss) carried forward -€377,660

    down €377,660 (-102.1%), from -€369,958 to -€747,619

  • Trade debts -€144,549

    down €144,549 (-26.4%), from €547,302 to €402,752

Income statement
  • Depreciation -€148,925

    down €148,925 (-92.8%), from €160,488 to €11,564

  • Staff costs +€112,297

    up €112,297 (+19.3%), from €580,767 to €693,064

  • Financial income -€51,701

    down €51,701 (-93.2%), from €55,475 to €3,775

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€369,958
Gross operating margin +€2,325
Staff costs -€112,297
Depreciation +€148,925
Other operating charges +€48
Financial income -€51,701
Financial charges +€2,253
Taxes +€2,745
Result 2025 -€377,660

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€713,118
Investment -€203,858
Financing +€34,976
Cash 2024 €1.3m
Net result for the year -€377,660
Depreciation +€11,564
Stocks and contracts -€57,233
Receivables within one year -€572,038
Deferred charges and accrued income -€426,925
Trade debts -€144,549
Tax, wage and social debts +€10,265
Other debts +€1,148
Accrued charges and deferred income +€842,311
Investment in fixed assets (net) -€203,858
Debts after one year +€9,332
Current portion of long-term debt +€25,644
Cash 2025 €377,014
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,063,342 €3,429,833 +€366,491 +12.0%
Fixed assets 21/28 €312,624 €504,918 +€192,295 +61.5%
Intangible fixed assets 21 €84,645 €273,863 +€189,217 +223.5%
Tangible fixed assets 22/27 €11,779 €14,856 +€3,077 +26.1%
Furniture and vehicles 24 €11,779 €14,856 +€3,077 +26.1%
Financial fixed assets 28 €216,200 €216,200 = 0.0%
Current assets 29/58 €2,750,718 €2,924,914 +€174,196 +6.3%
Stocks and contracts in progress 3 €37,226 €94,459 +€57,233 +153.7%
Stocks 30/36 €37,226 €94,459 +€57,233 +153.7%
Amounts receivable within one year 40/41 €255,863 €827,901 +€572,038 +223.6%
Trade receivables 40 €169,529 €698,993 +€529,465 +312.3%
Other amounts receivable 41 €86,335 €128,908 +€42,573 +49.3%
Cash at bank and in hand 54/58 €1,259,014 €377,014 -€882,001 -70.1%
Deferred charges and accrued income 490/1 €1,198,615 €1,625,540 +€426,925 +35.6%
Total equity and liabilities 10/49 €3,063,342 €3,429,833 +€366,491 +12.0%
Equity 10/15 €1,379,897 €1,002,237 -€377,660 -27.4%
Contributions 10/11 €1,492,158 €1,492,158 = 0.0%
Capital 10 €1,492,158 €1,492,158 = 0.0%
Issued capital 100 €1,492,158 €1,492,158 = 0.0%
Profit (loss) carried forward 14 -€369,958 -€747,619 -€377,660 -102.1%
Investment grants 15 €257,698 €257,698 = 0.0%
Amounts payable 17/49 €1,683,444 €2,427,595 +€744,151 +44.2%
Amounts payable after more than one year 17 €192,043 €201,375 +€9,332 +4.9%
Financial debts 170/4 €192,043 €201,375 +€9,332 +4.9%
Amounts payable within one year 42/48 €730,872 €623,379 -€107,493 -14.7%
Current portion of amounts payable after more than one year 42 €105,600 €131,244 +€25,644 +24.3%
Trade debts 44 €547,302 €402,752 -€144,549 -26.4%
Suppliers 440/4 €547,302 €402,752 -€144,549 -26.4%
Taxes, remuneration and social security 45 €77,193 €87,458 +€10,265 +13.3%
Taxes 450/3 €1,084 - -€1,084
Remuneration and social security 454/9 €76,109 €87,458 +€11,349 +14.9%
Other amounts payable 47/48 €777 €1,925 +€1,148 +147.7%
Accrued charges and deferred income 492/3 €760,530 €1,602,841 +€842,311 +110.8%
Remuneration, social security and pensions 62 €580,767 €693,064 +€112,297 +19.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €160,488 €11,564 -€148,925 -92.8%
Other operating charges 640/8 €2,297 €2,248 -€48 -2.1%
Gross operating margin 9900 €336,167 €338,492 +€2,325 +0.7%
Operating profit (loss) 9901 -€407,386 -€368,385 +€39,001 +9.6%
Financial income 75/76B €55,475 €3,775 -€51,701 -93.2%
Recurring financial income 75 €55,475 €3,775 -€51,701 -93.2%
Financial charges 65/66B €15,534 €13,281 -€2,253 -14.5%
Recurring financial charges 65 €15,534 €13,281 -€2,253 -14.5%
Profit (loss) for the period before taxes 9903 -€367,445 -€377,891 -€10,447 -2.8%
Income taxes 67/77 €2,514 -€231 -€2,745
Profit (loss) for the period 9904 -€369,958 -€377,660 -€7,702 -2.1%
Profit (loss) for the period to be appropriated 9905 -€369,958 -€377,660 -€7,702 -2.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.